The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape.
One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking...
